John D. Loike, PhD
John D. Loike is a bioethicist.
Is this your author page?
Make it work for you. Your KevinMD author page is one of the highest-ranking results for your name. An enhanced author page turns this page into a premium profile with your photo, biography, affiliations, publications, and links, publishes your accepted articles in 1 to 3 days, and comes with a guaranteed interview on The Podcast by KevinMD. See an example · See the enhanced author page → Cancel anytime.
Latest articles
Conditions and diseases
There is fear in the air. Fear that the COVID pandemic may not get under control because the virus is mutating so fast. Fear that the vaccines may not be effective against these new variants. But fear should not be…
There is fear in the air. Fear that the COVID pandemic may not get under control because the virus is mutating so fast. Fear that the vaccines may not be effective against these new variants. But fear should not be the driving force behind public health policy decisions. A measured analysis of facts and data is what is important.
With the WHO’s approval, the South African government …
Read more…
When is it ethical to stop a vaccination program?
Conditions and diseases
While the current COVID pandemic has created serious health challenges, there has been a dramatic increase in research examining the effects of vitamins on COVID infections. Many studies report the positive effects of vitamin D in boosting our immune system…
While the current COVID pandemic has created serious health challenges, there has been a dramatic increase in research examining the effects of vitamins on COVID infections. Many studies report the positive effects of vitamin D in boosting our immune system and protecting against COVID. Studies and seminars have shown that for those people who do not receive vitamin D from outdoor sun
…
Read more…
The FDA should consider vitamin D as a pharmaceutical agent for COVID
Conditions and diseases
To contain COVID-19 and re-open the economy, the U.S. should be performing 500,000 tests per day. We are nowhere near that number. Widespread implementation of CRISPR-based testing would address deficits in the current testing landscape. The most common method of…
To contain COVID-19 and re-open the economy, the U.S. should be performing 500,000 tests per day. We are nowhere near that number.
Widespread implementation of CRISPR-based testing would address deficits in the current testing landscape. The most common method of testing for COVID-19—reverse transcription-polymerase chain reaction (RT-PCR)—costs $100 per test, takes four-six hours to run, involves
…
Read more…
How CRISPR technology can solve our COVID-19 testing problems
Real physician voices, twice a week
Free, and one click to unsubscribe.
